
    
      This is a randomized clinical trial, which includes 320 newborns of both sexes and residents
      of the state of MÃ©xico, 160 newborns receive the vaccine OPV Birmex and 160 newborns receive
      the vaccine OPV Sanofi Pasteur
    
  